Skip to main content

Table 2 The levels of lipid indicators and pregnancy outcomes in GDM and non-GDM groups (means ± SD, n %)

From: Serum lipid levels in relation to clinical outcomes in pregnant women with gestational diabetes mellitus: an observational cohort study

 

Control group

(n = 273)

GDM group

(n = 359)

P

TG (mmol/L)

2.05 ± 0.97

2.38 ± 1.37

0.001

TC (mmol/L)

5.56 ± 0.92

5.42 ± 0.92

0.050

HDL-C (mmol/L)

2.02 ± 0.41

1.86 ± 0.42

<  0.001

LDL-C (mmol/L)

2.69 ± 0.75

2.61 ± 0.73

0.159

Apo A1 (g/L)

2.42 ± 0.41

2.37 ± 0.41

0.195

Apo B (g/L)

1.06 ± 0.31

1.04 ± 0.22

0.486

AIP

−0.02 ± 0.20

0.08 ± 0.24

<  0.001

Cesarean section (n, %)

64 (23.4)

131 (36.5)

<  0.001

Postpartum hemorrhage (ml)

397.27 ± 213.61

446.71 ± 264.82

0.012

Gestational weeks at birth (weeks)

39.67 ± 1.38

38.79 ± 1.29

< 0.001

Birth weight (g)

3445.95 ± 519.96

3362.63 ± 443.63

0.030

Body length (cm)

50.43 ± 1.75

50.08 ± 1.91

0.016

Prematurity (n, %)

5 (1.8)

19 (7.3)

0.002

Macrosomia (n, %)

35 (13.8)

24 (6.7)

0.009

Apgar 5 min score

9.98 ± 0.17

9.98 ± 0.17

0.982

  1. AIP Atherogenic index of plasma, Apo A1/B Apolipoprotein A1/B, BMI Body mass index, GDM Gestational diabetes mellitus, HDL-C High-density lipoprotein-cholesterol, LDL-C Low-density lipoprotein-cholesterol, SD Standard deviation, TC Total cholesterol, TG Triglycerides